Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin

被引：24
|
作者：
de Zwaan, Sally E. [3 ]
Iland, Harry J. [1 ]
Damian, Diona L. [2 ,3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Haematol, Sydney, NSW, Australia
[2] Univ Sydney, Dept Dermatol, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 01期
关键词：
corticosteroid adverse effects; diabetes mellitus; imatinib mesylate;
D O I：
10.1111/j.1440-0960.2008.00506.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
引用
收藏
页码：56 / 59
页数：4
相关论文
共 50 条
  • [21] Applying Intravenous Immunoglobulin and Negative-Pressure Wound Therapy to Treat Refractory Pyoderma Gangrenosum: A Case Report
    Jin, Shi-Ying
    Chen, Mei
    Wang, Feng-Yuan
    Wang, Fei
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2021, 20 (02): : 158 - 161
  • [22] Intravenous Immunoglobulins in the Treatment of Pyoderma Gangrenosum - a retrospective Analysis
    Walter, Lukas
    Bartels, Philipa
    Krieter, Manuel
    Von den Driesch, Peter
    Schultz, Erwin S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 172 - 172
  • [23] Refractory Pyoderma Gangrenosum in an Infant
    Etzler, Chloe
    Cannon, Sarah
    Hyde, Patrice
    PEDIATRIC DERMATOLOGY, 2015, 32 (01) : 156 - 157
  • [24] Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series
    Charles, Carlos A.
    Leon, Argentina
    Banta, Meggan R.
    Kirsner, Robert S.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (10) : 1095 - 1099
  • [25] Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease
    Friedman, S
    Marion, JF
    Scherl, E
    Rubin, PH
    Present, DH
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (01) : 1 - 7
  • [26] Successful Treatment of Pyoderma Gangrenosum Associated with Myelodysplastic Syndrome Using High-Dose Intravenous Immunoglobulin
    Tamaki, Kenichiro
    Nakazawa, Takashi
    Mamehara, Akira
    Tsuji, Goh
    Saigo, Katsuyasu
    Kawano, Seiji
    Morinobu, Akio
    Kumagai, Shunichi
    INTERNAL MEDICINE, 2008, 47 (23) : 2077 - 2081
  • [27] A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy
    ZHANG Xi-bao
    中华医学杂志(英文版), 2006, (14) : 1230 - 1232
  • [28] A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy
    Zhang Xi-bao
    He Yu-qing
    Zhou Hua
    Luo Quan
    Li Chang-xing
    CHINESE MEDICAL JOURNAL, 2006, 119 (14) : 1230 - 1232
  • [29] A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy
    ZHANG Xibao HE Yuqing ZHOU Hua LUO Quan and LI Changxing Department of Dermatology Guangzhou Institute of Dermatology Guangzhou China Department of Dermatology Shenzhen Dermatological Hospital Shenzhen China
    Chinese Medical Journal, 2006, (14) : 1230 - 1232
  • [30] The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum
    Hagman, JH
    Carrozzo, AM
    Campione, E
    Romanelli, P
    Chimenti, S
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2001, 12 (01) : 19 - 22
12345